Drug Profile
Brinzolamide/latanoprost
Alternative Names: Latanoprost/brinzolamideLatest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator Adapt Produtos Oftalmologicos
- Class Antiglaucomas; Eye disorder therapies; Prostaglandins; Small molecules; Sulfonamides; Thiazines
- Mechanism of Action Carbonic anhydrase inhibitors; Prostaglandin F2 alpha agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Glaucoma; Ocular hypertension
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for clinical-Phase-Unknown development in Glaucoma in Brazil (Ophthalmic, Drops)
- 04 Nov 2017 No recent reports of development identified for clinical-Phase-Unknown development in Ocular-hypertension in Brazil (Ophthalmic, Drops)
- 01 Dec 2014 Adapt Produtos Oftalmologicos terminates phase III trial in Ocular hypertension and Glaucoma in Brazil (NCT01721707) prior to initiation